5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Neoadjuvant Pertuzumab-containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER-2/neu-positive Breast Cancer: A Retrospective, Single Institution Experience

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Clinical Breast Cancer
          Clinical Breast Cancer
          Elsevier BV
          15268209
          December 2018
          December 2018
          : 18
          : 6
          : e1283-e1288
          Article
          10.1016/j.clbc.2018.07.008
          0ef8390f-c4bb-4d76-b931-eb76865f8e15
          © 2018

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article